Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing a breakthrough non-invasive treatment approach for amyotrophic lateral sclerosis (ALS), announced today ...

< Professor Markus Otto at the microscope: In a study, he and his colleagues showed that p-tau protein ... University Medicine Halle ...

MND Scotland says that around 450 people in the country are living with Motor Neurone Disease. One symptom that can easily be ...

There are 4 immunoassays for neurofilament light chain that demonstrate consistent performance in patients with ALS.

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

This article originally appeared in Research Colorado.Research at the University of Denver is showing promise for the ...

Needham & Company LLC reaffirmed their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a research report ...

Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ...

ITF Therapeutics LLC, the U.S. affiliate of Italfarmaco, today announced the opening of the company's new U.S. headquarters in Concord, Massachusetts. The 10,000-square-foot facility located at 575 ...

A study originally focusing on cancer has shown that amyloids — proteins typically linked to neurodegenerative diseases like ...

Dark organic glass found inside a skull appeared to be the fossilized brain of a male human who died during the 79 CE Mount ...